These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1450875)
41. Factors associated with climacteric symptoms and the use of hormone replacement therapy. Stadberg E; Mattsson LA; Milsom I Acta Obstet Gynecol Scand; 2000 Apr; 79(4):286-92. PubMed ID: 10746844 [TBL] [Abstract][Full Text] [Related]
42. [Psychosocial aspects of the climacteric]. Buddeberg C; Buddeberg-Fischer B Praxis (Bern 1994); 1995 Jun; 84(24):718-21. PubMed ID: 7792468 [TBL] [Abstract][Full Text] [Related]
43. A study on the use of medication for climacteric complaints in western Europe--II. Oddens BJ; Boulet MJ; Lehert P; Visser AP Maturitas; 1994 May; 19(1):1-12. PubMed ID: 7935027 [TBL] [Abstract][Full Text] [Related]
44. Prevalence of vasomotor, psychological, psychosomatic and sexual symptoms in perimenopausal and recently postmenopausal Greek women: association with demographic, life-style and hormonal factors. Grigoriou V; Augoulea A; Armeni E; Rizos D; Alexandrou A; Dendrinos S; Panoulis K; Lambrinoudaki I Gynecol Endocrinol; 2013 Feb; 29(2):125-8. PubMed ID: 22849709 [TBL] [Abstract][Full Text] [Related]
45. The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI. Nappi RE; Davis SR Climacteric; 2012 Jun; 15(3):267-74. PubMed ID: 22612614 [TBL] [Abstract][Full Text] [Related]
46. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency. Whittington R; Faulds D Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233 [TBL] [Abstract][Full Text] [Related]
47. [Low-dose estrogens in the treatment of the climacteric syndrome]. Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038 [TBL] [Abstract][Full Text] [Related]
48. Estrogen and alternative therapy of the menopausal patient. Lichten EM Prim Care; 1978 Dec; 5(4):607-14. PubMed ID: 253359 [TBL] [Abstract][Full Text] [Related]
49. [Prevalence of sexual dysfunction in climacteric women. Influence of menopause and hormone replace therapy]. Blümel JE; Araya H; Riquelme R; Castro G; Sánchez F; Gramegna G Rev Med Chil; 2002 Oct; 130(10):1131-8. PubMed ID: 12491830 [TBL] [Abstract][Full Text] [Related]
50. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD; Menopause; 2000; 7(4):273-81. PubMed ID: 10914621 [TBL] [Abstract][Full Text] [Related]
57. [Estrogens in menopause--therapy and prevention. I. Hormone substitution in climacteric and postmenopause]. Wuttke W Internist (Berl); 1996 Apr; 37(4):402-5. PubMed ID: 8655280 [No Abstract] [Full Text] [Related]
59. [Indications and controindications of hormone replacement therapy in menopause]. Fichera M; Rinaldi N; Tarascio M; Taschetta S; Caldaci LM; Catavorello A; La Rosa B; Panella MM Minerva Ginecol; 2013 Jun; 65(3):331-44. PubMed ID: 23689177 [TBL] [Abstract][Full Text] [Related]
60. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Huang KE; Xu L; I NN; Jaisamrarn U Maturitas; 2010 Mar; 65(3):276-83. PubMed ID: 20018469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]